Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jobin, R. M.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jobin, R. M.
Right arrow Articles by Stojilkovic, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 35, Issue of August 30, 1996 pp. 21200-21208
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Expression of Purinergic Receptor Channels and Their Role in Calcium Signaling and Hormone Release in Pituitary Gonadotrophs
INTEGRATION OF P2 CHANNELS IN PLASMA MEMBRANE- AND ENDOPLASMIC RETICULUM-DERIVED CALCIUM OSCILLATIONS*

(Received for publication, February 14, 1996, and in revised form, June 4, 1996)

Melanija Tomic , Richard M. Jobin , Leoncio A. Vergara and Stanko S. Stojilkovic Dagger

From the Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda Maryland 20892

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The role of ATP as a positive feedback element in Ca2+ signaling and secretion was examined in female rat pituitary gonadotrophs. ATP and ADP, but not AMP or adenosine, induced a dose- and extracellular Ca2+-dependent rise in [Ca2+]i in identified gonadotrophs in a Mg2+- and suramin-sensitive manner. ATP, adenosine-5'-O-(3-thiotriphosphate), adenosine-5'-O-(1-thiotriphosphate), 2-methylthio-ATP, and 3'-O-(4-benzoyl)benzoyl-ATP were roughly equipotent in rising [Ca2+]i in gonadotrophs, while ADP was effective only at submillimolar concentration range, and none of these compounds permeabilized the cells. On the other hand, alpha ,beta -methylene-ATP, beta ,gamma -methylene-ATP, and UTP were unable to induce any rise in [Ca2+]i. This pharmacological profile is consistent with expression of P2X2 and/or P2X5 purinergic receptor channels. Patch-clamp experiments showed that ATP induced an inward depolarizing current in gonadotrophs clamped at -90 mV, associated with an increase in [Ca2+]i. The ATP-induced [Ca2+]i response was partially inhibited by nifedipine, a blocker of voltage-sensitive Ca2+ channels (VSCC), but was not affected by tetrodotoxin, a blocker of voltage-sensitive Na+ channels. Thus, the P2-depolarizing current itself drives Ca2+ into the cell, but also activates Ca2+ entry through VSCC. In accord with this, low [ATP] induced plasma membrane-dependent [Ca2+]i oscillations in quiescent cells, and increased the frequency of spiking in spontaneously active cells. ATP-induced Ca2+ influx also affected agonist-induced and InsP3-dependent [Ca2+]i oscillations by increasing the frequency, base line, and duration of Ca2+ spiking. In addition, ATP stimulated gonadotropin secretion and enhanced agonist-induced gonadotropin release. ATP was found to be secreted by pituitary cells during agonist stimulation and was promptly degraded by ectonucleotidase to adenosine. These observations indicate that ATP represents a paracrine/autocrine factor in the regulation of Ca2+ signaling and secretion in gonadotrophs, and that these actions are mediated by P2 receptor channels.


INTRODUCTION

Adenosine trisphosphate is frequently stored in secretory granules together with other neurotransmitters and hormones and is often cosecreted during agonist stimulation. Once released into the extracellular medium, ATP may bind to its plasma membrane purinergic receptors (P2),1 leading to increases in [Ca2+]i and potentiation of the exocytosis (1, 2, 3). ATP receptors belong to two major groups: G protein-coupled receptors (P2U and P2Y), whose activation causes Ca2+ release from its intracellular stores, and plasma membrane receptor channels (P2X), whose activation promotes Ca2+ influx (4, 5). Thus, the action of ATP during exocytosis may represent a positive feedback mechanism or self-potentiation of the calcium signaling and secretion (autocrine regulation). In addition, ATP may diffuse and activate P2 receptors in neighboring cells (paracrine regulation). On the other hand, ATP cannot act as a typical hormone, since it is rapidly degraded by several ecto-ATPases (4).

Purinergic receptor channels have been identified in both excitable and non-excitable cells (6, 7, 8, 9). Calcium has been shown to carry current through these channels, and the permeability of Ca2+ versus Na+ varies widely among cells (10). Furthermore, since ATP-controlled channels lead to depolarization, [Ca2+]i response to ATP could result from activation of voltage-sensitive calcium channels (VSCC), in addition to the direct entry of Ca2+ through purinergic channels (10). In several cell types that secrete by exocytosis, including pituitary cells (11), spontaneous firing of action potentials (APs) at resting potential is associated with [Ca2+]i oscillations, but the possible participation of P2 receptor channels in such Ca2+ spiking (termed the plasma membrane oscillator) has not been addressed. In general, these channels could modulate secretion by changing the frequency, amplitude, or duration of APs and their resulting increases in [Ca2+]i. In accord with this, an ATP analog was found to increase the firing rate in spontaneously active noradrenergic neurons at the resting potential (12).

ATP-gated Ca2+ channels may also represent the Ca2+ influx pathway that sustains InsP3-induced and endoplasmic reticulum (ER)-derived Ca2+ spiking and Ca2+-controlled exocytosis. Such oscillations, that have frequency of spiking controlled by agonist concentration, were observed in both excitable and nonexcitable cells (11, 13, 14). In excitable cells, VSCC supply the cells with Ca2+ during sustained stimulation (15), while in several non-excitable cells, Ca2+ entry occurs through store-operated calcium channels (16). However, the role of P2 receptor channels as exclusive or additional Ca2+ influx pathways in ER-derived oscillations in both cell types has not been addressed.

Calcium-mobilizing P2U receptors have been identified in pituitary cells (17, 18, 19, 20, 21). We have recently observed that rat pituitary gonadotrophs express P2 receptor channels. Since gonadotrophs are excitable (22), and agonist stimulation leads to the activation of ER-derived oscillations (15), these cells were employed to address several of the questions raised above. We have examined ATP-induced activation of the plasma membrane oscillator in silent cells, and the modulation of its activity in spontaneously active cells. Furthermore, the effects of exogenous ATP on gonadotropin-releasing hormone (GnRH)-induced and InsP3-controlled Ca2+ oscillations were analyzed. We have also evaluated the impact of modulation of the plasma membrane and ER oscillators by ATP on gonadotropin secretion. In addition, the cosecretion of ATP during agonist stimulation was monitored. Our results indicate that ATP has a role as a positive feedback element in agonist-induced Ca2+ signaling and gonadotropin secretion.


MATERIALS AND METHODS

Chemicals

GnRH was obtained from Peninsula Laboratories, fura-2 AM and mag-fura-2 AM from Molecular Probes; streptolysin O from Difco; tetrodotoxin, suramin, and adenosine-5'-O-(1-thiotriphosphate) from Calbiochem; and pyruvate kinase and myokinase from Boehringer Mannheim. All other chemicals were purchased from Sigma.

Pituitary Cell Culture

Experiments were performed on anterior pituitary cells from normal and ovariectomized female Sprague-Dawley rats obtained from Charles River Inc. (Wilmington, MA). Groups of 50 anterior pituitary glands were rinsed several times in dispersion medium: Dulbecco's phosphate-buffered saline, without Ca2+ and Mg2+, containing 0.1% bovine serum albumin (BSA), 100 units/ml penicillin, and 100 µg/ml streptomycin. They were then minced into 0.7-mm cubes with a tissue chopper (Brinkmann Instruments Inc, Westbury, NY), washed in dispersion medium, and incubated for 1 h in a shaking waterbath at 37 °C in 50 ml of dispersion medium containing 75 mg of trypsin. This medium was discarded and replaced by 50 ml of fresh dispersion medium containing 75 mg of trypsin inhibitor and 10 µg of DNase for an additional 10-min incubation. The pituitary tissue was then disrupted by repeated aspiration into a plastic transfer pipette and the dispersed cells were filtered through nylon mesh (80 µm). Viable cells were counted in the presence of trypan blue and cultured in medium 199 containing Earle's salts, sodium bicarbonate, 10% horse serum, and antibiotics.

Measurements of Calcium Ion Concentration

For cytosolic and luminal Ca2+ concentration measurements, cells (106/dish) were plated on coverslips coated with poly--lysine and cultured in medium 199 containing Earle's salts, sodium bicarbonate, 10% horse serum, and antibiotics. The next day, the cells were incubated at 37 °C for 60 min with 2 µ fura-2 AM for cytosolic Ca2+ measurements, and for 90 min with 7 µ mag-fura-2 AM for luminal Ca2+ measurements. The extracellular buffer used in Ca2+ measurements was phenol red-free M199 with Hank's salts or modified Krebs-Ringer without Mg2+. When the effects of sodium ions were studied, NaCl was substituted with N-methyl--glucamine chloride. Coverslips with cells were washed with phenol red-free buffer and mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor Digital Fluorescence Microscopy System (Atto Instruments, Rockville, MD). Cells were examined under a 40× oil immersion objective during exposure to alternating 340 and 380 nm light beams, and the intensity of light emission at 520 nm was measured. In this way, light intensities and their ratio, F340/F380, which reflects changes in Ca2+ concentration, were followed in several single cells simultaneously. GnRH was added as a final stimulus in each experiment where [Ca2+]i kinetics was followed to identify the cell as a gonadotroph and to compare relative [Ca2+]i responses induced by ATP (or its analogues) to the maximal [Ca2+]i amplitudes induced by GnRH.

``Intracellular medium'' used in experiments with permeabilized cells contained 124 m potassium glutamate, 6 m magnesium acetate, 0.2 m EGTA, 20 m PIPES, 0.1% BSA, and its pH was adjusted by KOH. In cells loaded with mag-fura-2, decreases in fluorescence were observed 1-5 min after addition of streptolysin O; F340 dropped by about 60%, whereas F380 decreased by about 80%, increasing the F340/F380 ratio. Such a decrease in fluorescence is due to permeabilization and consequent leakage of mag-fura-2 from the cytosol, and the remaining dye is believed to be compartmentalized within the endoplasmic reticulum (23). Whereas the initial F340/F380 ratio reflects the concentrations of Mg2+ and Ca2+ in the cytosol, ratios in permeabilized cells reflect primarily the concentration of Ca2+ in ER (23, 24).

Simultaneous Measurements of [Ca2+]i and ATP-induced Current

Simultaneous measurements of [Ca2+]i and current in single isolated gonadotrophs were made as described previously (25). The cells were plated on glass coverslips (106 cells/dish) and kept in culture for 2-3 days at 37 °C in an atmosphere of 95% air and 5% CO2. Experiments were carried out at room temperature (20-25 °C). Cells were loaded with indo-1 AM at room temperature (20-25 °C) by incubation for 30-60 min in a loading solution containing 2 µ indo-1 AM and 0.02% pluronic acid (Molecular Probes, Inc., Eugene, OR), and the following composition of salts (in m): 140 NaCl, 5 KCl, 2.6 CaCl2, 1 MgCl2, 5 NaHepes, 5 glucose, pH = 7.4. Coverslips were mounted in an open chamber designed to fit in the stage of an inverted epifluorescence microscope (Carl Zeiss, ICM 405, Oberkochen, Germany) equipped with a photon counter system (Photon Technology International Inc., Brunswick, NJ) to measure simultaneously the intensity at 405 and 480 nm from the acid form of indo-1 trapped inside the cells and excited at 365 nm. The data were acquired using a PC provided with an acquisition board. The software (OSCAR) provided with the system allowed corrections to be made for the background intensity of both the light emitted at 405 and 485 nm. Results were expressed as the corrected ratio between the fluorescent signals recorded at 410 and 485 nm.

The open recording chamber allowed access to cells for electrophysiological studies. Whole-cell currents under voltage-clamp conditions were measured using the nystatin-perforated membrane patch method (58). Membrane currents were recorded using an EPC-7 amplifier (List-Electronics, Darmstadt-Eberstadt, Germany). Patch pipettes were pulled using a BB-CH-PC (Mecanex, Geneva, Switzerland) from microhematocrit capillary tubes. Pipettes filled with a high [K+] solution (in m: 20 KCl, 120 potassium aspartate, 10 KHepes, 3 MgCl2, pH 7.2, and 200 µg/ml nystatin) had tip resistance in the range from 2 to 4 MOmega . Acquisition of the light signals emitted at 405 and 485 nm, and electrophysiological recording were synchronized using a common external trigger logic pulse.

Measurements of LH and ATP

Column perifusions were performed on 3-day-old cultured cells under previously reported conditions (26). Briefly, 2 × 107 cells were incubated with preswollen Cytodex-1 beads in 60 mm culture dishes, and perifused with Hanks' M199 containing 20 m HEPES and 0.1% BSA for 60 min at a flow rate of 0.6 ml/min. After agonist and/or ATP stimulation, fractions were collected every minute and stored at -20 °C. LH was determined by radioimmunoassay, using the reagents and standards provided by the National Pituitary Agency (Baltimore, MD).

For measurement of ATP secretion and degradation, columns were perifused with Krebs-Ringer medium without Mg2+ at a flow rate of 0.15 ml/min. ATP secretion and degradation was also examined in static cultures (0.5 × 106 cells/well). The concentration of ATP in the effluent was determined by an ATP bioluminescent assay kit (Sigma) in an AutoLumat LB 953 (Berthold, Wildbad, Germany) by injection of 100 µ assay solution into an aliquot of 100 µ sample. Calibration curves were constructed from measurements in standard solutions, which were diluted in the same medium as the corresponding solutions of unknown ATP concentration. Detection limit of the assay was 0.02 n.

Total concentration of adenosine nucleotides was also measured in several experiments, by employing the following enzymatic reactions to convert ADP and AMP to ATP (27, 28),
AMP + ATP <LIM><OP><ARROW>→</ARROW></OP><UL>myokinase</UL></LIM> 2ADP
2ADP + 2PEP <LIM><OP><ARROW>→</ARROW></OP><UL>pyruvate kinase</UL></LIM> 2ATP + 2pyruvate
<SC>Reactions</SC> 1 <SC>and</SC> 2
where PEP is phospho(enol)pyruvate.

Aliquots of 50 µl of sample were added to 50 µl of the rephosphorylation mixture (10 units/ml myokinase, 6 units/ml pyruvate kinase, 1.5 m PEP, 25 m Hepes, 15 m KOH, 10 m MgSO4) and after 1 h at room temperature, ATP concentration was measured as described above. Due to relatively high bioluminescence of the enzyme solution, detection limit of the measurements of total adenosine nucleotides concentration was increased to 10 n. In the control experiments, the recovery of AMP was higher than 95%.


RESULTS

Extracellular Ca2+ Dependence of ATP Actions in Gonadotrophs

Addition of ATP induced a rapid increase in [Ca2+]i in single rat pituitary gonadotrophs, which were identified by addition of GnRH at the end of recording (Figs. 1, 2, 3, 4, 5). Different patterns of [Ca2+]i responses to ATP in single rat pituitary gonadotrophs bathed in Ca2+- and Mg2+-containing medium were observed (Fig. 1, left panel). A Ca2+ spike followed by a plateau was elicited by addition of 100-1000 µ ATP, and a monophasic long-lasting [Ca2+]i increase or low amplitude fluctuations in [Ca2+]i were observed at the 1-100 µ concentration range. The plateau induced by ATP was always lower than GnRH-induced spike. Furthermore, GnRH-induced [Ca2+]i responses after prolonged exposure to ATP were comparable to those induced by GnRH itself. This indicates that no obvious depletion of the intracellular Ca2+ pool was induced by ATP, as usually observed upon activation of G protein-coupled receptors.


Fig. 1. Concentration dependence of ATP-induced [Ca2+]i responses in single rat pituitary gonadotrophs. Left panel, representative traces of three different patterns as a response to 1 m (upper trace), 100 µ (middle trace), and 10 µ ATP (lower trace). Cells were bathed in medium 199 containing 0.8 m MgSO4·7H2O and 1.2 m CaCl2. Upper right panel, recording from a single gonadotroph stimulated subsequently by 1, 10, and 100 µ ATP, and 100 n GnRH. Lower right panel, ATP-induced [Ca2+]i responses (relative to 100 n GnRH-induced response) as a function of ATP concentration. In order to identify gonadotrophs and compare ATP- with GnRH-induced amplitudes of [Ca2+]i responses, 100 n GnRH was added at the end of these and the following experiments. Data points are the means ± S.E. of at least 10 measurements. Cells in these experiments were bathed in modified Krebs-Ringer buffer containing 1.2 m CaCl2 and no Mg2+.
[View Larger Version of this Image (19K GIF file)]


Fig. 2. The role of extracellular Ca2+ in ATP-induced [Ca2+]i responses. ATP induced no [Ca2+]i response in cells bathed in Ca2+-deficient medium (panel A), but did so after Ca2+ was returned to the bathing solution (panel B, upper trace). Ca2+ per se had no significant effect (panel B, lower trace). In a patch-clamped gonadotroph identified by prior treatment with GnRH, ATP induced an inward depolarizing current (panel C).
[View Larger Version of this Image (16K GIF file)]


Fig. 3. Characterization of the depolarizing action of ATP in gonadotrophs. A, participation of voltage-sensitive calcium channels in ATP-induced [Ca2+]i responses. In cells bathed in the presence of 500 n nifedipine, no spontaneous fluctuations in [Ca2+]i were observed, and addition of ATP was followed by a non-oscillatory increase in [Ca2+]i (left panel). Addition of nifedipine during ATP stimulation was followed by reduction but not abolition of the [Ca2+]i responses (right panel). B, the lack of effect of tetrodotoxin (TTX) on ATP-induced [Ca2+]i response. C, stimulatory action of 70 m Na+ on ATP-induced Ca2+ entry (right panel), and the lack of effect of Na+ alone on [Ca2+]i (left panel).
[View Larger Version of this Image (24K GIF file)]


Fig. 4. Pharmacological characterization of extracellular ATP action in gonadotrophs (I). A and B, UTP and alpha , beta -methylene-ATP had no effect on [Ca2+]i. C, effects of suramin, a P2 receptor antagonist, on ATP-induced [Ca2+]i response. D, 3'-O-(4 benzoyl)benzoyl-ATP induced [Ca2+]i responses with magnitude comparable to those produced by ATP. E, effects of Mg2+ on ATP-induced [Ca2+]i response. Raw fluorescence signals recorded at two excitation wavelengths are presented in the bottom panel, while their ratio, reflecting [Ca2+]i changes, is shown in upper panel.
[View Larger Version of this Image (26K GIF file)]


Fig. 5. Pharmacological characterization of extracellular ATP action in gonadotrophs (II). Adenosine-5'-O-(1-thiotriphosphate) (panel A), adenosine-5'-O-(3-thiotriphosphate) (panel B), and 2-methylthio-ATP (panel C) induced [Ca2+]i responses with magnitudes comparable to those produced by ATP, while ADP was effective only at submillimolar concentration range (panel D).
[View Larger Version of this Image (23K GIF file)]

The dependence of Ca2+ response on ATP concentration was not only indicated by the pattern of Ca2+ response, but also by its amplitude; exposure of a single gonadotroph to increasing ATP concentrations caused a step-like increase in [Ca2+]i (Fig. 1, upper right panel). A concentration-response curve (Fig. 1, lower right panel) was derived by expressing ATP-induced [Ca2+]i increases in Mg2+-deficient medium in relation to the GnRH-induced response of the same cell. The lowest ATP concentration that gave a detectable response was 1 µ, and a plateau was observed at 100 µ ATP; fitting a logistic function to the data gave an EC50 of 8 µ.

In Ca2+-deficient medium, ATP did not increase [Ca2+]i (Fig. 2A), but the subsequent introduction of 1.2 m Ca2+ into the medium increased [Ca2+]i in a manner comparable to the ATP-induced response (Fig. 2B, upper trace). Addition of Ca2+ alone had a negligible effect on [Ca2+]i (Fig. 2B, lower trace). The ATP-induced [Ca2+]i response was therefore generated by an influx of Ca2+ across the plasma membrane and not by Ca2+ released from its intracellular stores, indicating that gonadotrophs from ovariectomized female rats express purinergic P2 receptor channels.

Further evidence that ATP does not induce Ca2+ mobilization in gonadotrophs was obtained in experiments with permeabilized cells where changes in luminal Ca2+ concentration were measured. It has been shown that GnRH-induced Ca2+ release from the intracellular pool occurs in permeabilized rat gonadotrophs under certain conditions and is primarily dependent on the concentration of free Ca2+ in the medium (24). Similar responses were observed in permeabilized gonadotrophs upon stimulation by endothelin-1, as well as by InsP3. In contrast to these agonists, ATP did not induce detectable Ca2+ release in such a system (data not shown).

Pituitary gonadotrophs express several plasma membrane channels, including two types of VSCC and voltage-sensitive Na+ channels (22). To exclude the possible participation of these channels in the ATP-induced [Ca2+]i response, patch-clamp techniques with simultaneous measurements of current and [Ca2+]i responses were employed. Fig. 2C shows a whole-cell recording from a nystatin-perforated gonadotroph held at -50 mV. At this potential, 10 n GnRH evoked a typical outward IK(Ca) current (upper panel) that was driven by changes in [Ca2+]i (bottom panel). In this experiment, 100 n ATP was added in the continuous presence of the agonist, and after the oscillatory response was extinguished due to depletion of intracellular Ca2+ stores. Prior to application of 100 µ ATP, the cell was hyperpolarized to exclude any participation of VSCC in current response. Under these conditions, ATP induced an inward (depolarizing) current of about 50 pA in cells bathed in normal Krebs-Ringer buffer. An increase in [Ca2+]i was observed in parallel to the current response, confirming that Ca2+ entry occurs through the plasma membrane channels that are distinct from VSCC. However, the amplitude of this response was reduced when compared to responses in intact cells. Furthermore, in contrast to cells expressing multiphasic inward currents (29), ATP induced a monophasic response in gonadotrophs, suggesting the expression of a single class of purinergic channels.

In additional studies, we have employed two blockers of VSCC, nifedipine and verapamil, and a blocker of voltage-sensitive Na+ channels, tetrodotoxin. The ATP-induced [Ca2+]i response was not abolished in gonadotrophs treated with nifedipine (Fig. 3A) and verapamil (results not shown). However, the addition of nifedipine to ATP-stimulated cells decreased the plateau of [Ca2+]i response, but the newly achieved plateau was always above basal [Ca2+]i. These observations, and results presented in Fig. 2C, indicate a dual action of ATP in gonadotrophs: direct stimulation of Ca2+ influx through its own channels and consequent influx through dihydropyridine-sensitive VSCC.

In contrast to the VSCC blockers, tetrodotoxin was ineffective when applied before or during ATP stimulation (Fig. 3B), indicating that ATP does not act through Na+ channels. The effects of ATP on the [Ca2+]i response were further examined in normal Krebs-Ringer buffer (controls) and in buffer in which Na+ was replaced by the non-permeant ion, N-methyl--glucamine. As shown in Fig. 3C, the addition of Na+ per se was ineffective, while its addition to ATP-stimulated gonadotrophs further increased [Ca2+]i. These results indicate that P2 receptor channels conduct both Na+ and Ca2+ ions, which are responsible for depolarization of the cells and subsequent activation of VSCC.

Pharmacological Characterization of P2 Receptor Channels in Gonadotrophs

Recently, several subtypes of P2X and P2Y receptors were cloned, and it is possible to a certain extent to distinguish them pharmacologically, employing several P2 agonists and antagonists. In pituitary cell types other than gonadotrophs, UTP induced [Ca2+]i response (results not shown), but no response was observed in freshly dispersed and cultured gonadotrophs from ovariectomized rats (Fig. 4A), confirming the absence of G-protein-coupled P2U and P2Y receptors in these cells. Two additional ATP agonists, alpha ,beta -methylene-ATP (Fig. 4B) and beta ,gamma -methylene-ATP (results not shown) did not induce a [Ca2+]i response, arguing against the expression of P2Y phospholipase C-coupled receptors in gonadotrophs. The action of ATP and its analogs was also analyzed in gonadotrophs from cycling female rats, and the same extracellular Ca2+ dependence of [Ca2+]i response was found. In both cell types, the Ca2+ dependence of ATP action was observed over temperature range of a 22-35 °C, and in cells immediately after dispersion, as well as cells cultured for 1-4 days. Thus, it is unlikely that G protein-coupled purinergic (P2Y or P2U) receptors are coexpressed in pituitary gonadotrophs from Sprague-Dawley rats.

The lack of effects of alpha ,beta -methylene-ATP and beta ,gamma -methylene-ATP also argues against the expression of P2X1 (30) and P2X3 (31, 32) receptor channels in pituitary gonadotrophs. Furthermore, inhibiting effects of suramin, a P2 receptor antagonist, on ATP-induced [Ca2+]i response (Fig. 4C) exclude the possibility that P2X4 and P2X6 receptor subtypes (33, 34, 35) are expressed in these cells. The highly potent agonist for the P2X7, i.e. P2Z purinergic receptor channels (36), 3'-O-(4-benzoyl)benzoyl-ATP (BzATP) induced rise in [Ca2+]i in gonadotrophs (Fig. 4D), but it was equally potent as ATP. Except for inducing an inward current associated with a rise in [Ca2+]i, ATP and BzATP also induce lysis of cells expressing native and cloned channels through the formation of the membrane pores permeable to large molecules (28, 36). In gonadotrophs, ATP and BzATP did not show the lysic effects at 22-35 °C, arguing against the expression of P2X7 channels. As shown in Fig. 4E, addition of Mg2+ to ATP-stimulated cells caused a rapid drop in [Ca2+]i to its basal value, consistent with conclusion that ATP4- is responsible for the [Ca2+]i increase. Moreover, the ability of suramin and Mg2+ to decrease the ATP-induced rise in [Ca2+]i confirms that gonadotrophs were not permeabilized by ATP. Furthermore, the rate of fluorescence decrease was not enhanced by application of ATP (Fig. 4E), showing that leakage of fura-2 did not occur.

In addition to BzATP, ATPalpha S (Fig. 5A), ATPgamma S (Fig. 5B), and 2 methylthio-ATP (2-MeS-ATP) (Fig. 5C), were found to be roughly equipotent as agonists. Such pharmacological profile is comparable but not identical with those of P2X2 (37) and P2X5 (35) cloned channels. P2X2 channel show a lower sensitivity to ATP (EC50 of 60 µ), that was increased in the presence of Zn2+ (37). In contrast, addition of Zn2+ (10 µ) did not affect ATP (1-100 µ)-induced [Ca2+]i responses in gonadotrophs (data not shown). There is also an obvious difference in the amplitude of current triggered by ATP in cells expressing P2X2 channel and gonadotrophs. On the other hand, the amplitude of P2 current in gonadotrophs was comparable to that observed in cells expressing P2X5 channel. In addition, half-maximal concentrations for ATP, 2-MeS-ATP, and ATPgamma S for this channel are comparable to that of gonadotrophs. P2X5 channel was reported to be responsive to ADP, with an EC50 of 270 µ (35). We have also observed the effects of ADP at submillimolar concentration range (Fig. 5D), but in our experiments this observation should be considered with reservation, because ADP contained 0.4% ATP. Thus, such quantitative differences in pharmacological profiles are not sufficient to distinguish which subtype(s) of P2 channels are expressed in gonadotrophs, P2X5, and/or P2X2.

Effects of ATP on Oscillatory Ca2+ Signaling

Pituitary gonadotrophs show spontaneous firing of APs and AP-driven low amplitude oscillatory Ca2+ signals (22). To evaluate the effects of ATP on this oscillator, the depolarizing action of P2 receptor channels was evaluated in quiescent and spontaneously active cells. As shown in Fig. 6A, addition of 10 µ ATP (in the presence of Mg2+) induced Ca2+ spiking in a silent gonadotroph (left panel), similar to that observed in spontaneously active cells (right panel). Furthermore, in spontaneously active cells, ATP increased frequency of spiking in a concentration-dependent manner (right panel). Addition of Mg2+ abolished the activation of the plasma membrane oscillator by ATP (panel B, left), while in spontaneously active cells addition of Mg2+ did not affect the pattern of spiking (panel B, right). These results further confirm that stimulation of P2 receptor channels depolarizes the cells and activates the plasma membrane oscillator. Nevertheless, ATP is not essential for the endogenous operation of the plasma membrane oscillator.


Fig. 6. Effects of ATP on the plasma membrane oscillator. A, initiation of Ca2+ spiking in silent cells by 10 µ ATP (left panel) and modulation of the frequency of spiking in spontaneously active cells by 10 and 100 µ ATP (right panel). B, addition of 5 m Mg2+ abolished ATP-induced Ca2+ oscillations but did not affect Ca2+ spiking in spontaneously active cells. C, addition of 100 µ ATP abolished both spontaneous and ATP-induced oscillatory patterns of Ca2+ spiking. D, in cells stimulated with 100 µ ATP, addition of suramin (70 µ) and Mg2+ (5 m) reestablished the oscillatory pattern of Ca2+ spiking. The cells were identified as gonadotrophs by addition of GnRH at the end of each experiment (data not shown).
[View Larger Version of this Image (31K GIF file)]

In cells depolarized by 50 m KCl, the operation of the plasma membrane oscillator was inhibited and a non-oscillatory high amplitude increase in [Ca2+]i was detected (38). Similarly, in both ATP-activated and spontaneously active cells, addition of high concentrations of ATP caused the transformation of the oscillatory [Ca2+]i patterns to a high amplitude non-oscillatory increase in [Ca2+]i (Fig. 6C). The subsequent addition of suramin or Mg2+ frequently recovered the oscillatory response (Fig. 6D). These results further indicate that the P2 influx current is depolarizing and that the operation of the plasma membrane oscillator can be initiated, facilitated, or inhibited, depending on the ambient ATP4- concentration.

In addition to the plasma membrane oscillator, an ER oscillator is also operative in gonadotrophs. Ca2+-mobilizing agonists including GnRH, ET-1, and PACAP induce rapid (5-25 spikes/min), [Ca2+]i oscillations that may last 3-10 min in cells bathed in Ca2+-deficient medium, and up to 40 min in Ca2+-containing medium (15). It is therefore reasonable to expect that extracellular ATP will affect signaling by enhancing the existing Ca2+ influx in GnRH-stimulated cells. As shown in Fig. 7A, addition of ATP during the sustained extracellular Ca2+-dependent phase of signaling induced two types of responses. In some cells, it increased [Ca2+]i above spike amplitude and abolished spiking. In others, addition of ATP reinitiated or remodulated agonist-induced Ca2+ spiking. In general, the first type of response was observed at higher (above 100 µ) and the second type of response at lower (below 100 µ) ATP concentrations in cells bathed in Mg2+-containing medium. Low concentrations of ATP not only raised the base line of the oscillations, but also increased the frequency of spiking (Fig. 7B). Thus, if ATP-induced Ca2+ influx is lower, the ER oscillator can integrate it without disrupting the oscillatory mode of signaling. Otherwise, the oscillatory response is abolished, presumably due to interference by Ca2+ influx with the bidirectional action of [Ca2+]i on InsP3 channel activity (39, 40, 41).


Fig. 7. Effects of extracellular ATP on GnRH-induced [Ca2+]i responses. A, the patterns of Ca2+ signaling in response to ATP. B, effect of ATP on GnRH-induced sustained oscillatory Ca2+ response. Calcium signals were initiated by 100 n GnRH, and cells were subsequently stimulated with 100 µ (panel A, upper and lower traces), 500 µ (two middle traces), and 7 µ ATP (panel B). The frequency of Ca2+ spiking (panel B, above) was calculated as a reciprocal value of the time between two successive Ca2+ peaks.
[View Larger Version of this Image (29K GIF file)]

Effects of Extracellular ATP on Basal and GnRH-induced LH Release

As already reported (19), perifused pituitary cells attached to beads release LH in response to ATP stimulation. In our experiments, the threshold concentration of ATP to activate exocytosis in cells bathed in Mg2+-containing medium was higher than 5 µ. The peak of ATP-induced LH concentration was comparable to the value of the GnRH-induced plateau when the ATP concentration was 10 µ or higher (Fig. 8A). Interestingly, although ATP induced long lasting and slowly falling [Ca2+]i increases in isolated cells, the kinetics of ATP-induced LH secretion in perifused cells had a different profile; a peak with a rapid drop to near-basal values (see also ``Degradation of ATP by Pituitary Cells'').


Fig. 8. Effects of ATP on basal and GnRH-induced LH secretion from perifused pituitary cells. A, comparison of the effects of ATP and GnRH on LH release. Shaded bars indicate the duration of ATP and GnRH pulses. B, Cells were stimulated with GnRH in the absence (controls) and presence of ATP (+ATP). C, effects of ATP on the sustained GnRH-induced LH response. Shaded bar indicates the duration of the ATP pulse.
[View Larger Version of this Image (21K GIF file)]

In GnRH-stimulated cells, addition of 10 µ ATP further enhanced the secretory response. In perifused cells isolated from random cycling female rats, simultaneous addition of GnRH and ATP led to an amplification of secretion during the sustained extracellular Ca2+-dependent phase (Fig. 8B). In pituitary cells from ovariectomized rats, addition of ATP during the sustained phase of GnRH stimulation also enhanced gonadotropin secretion (Fig. 8C). The effect of ATP on basal and GnRH-induced gonadotropin secretion was concentration-dependent, with an EC50 similar to that observed in [Ca2+]i measurements, and was abolished in cells bathed in Ca2+-deficient medium (data not shown).

Secretion and Degradation of ATP by Pituitary Cells

The finding that ATP, by enhancing Ca2+ influx, can prolong and amplify GnRH-induced [Ca2+]i oscillations, as well as induce LH secretion, makes ATP a candidate for a positive feedback element in agonist-induced Ca2+ signaling and hormone secretion. However, under conditions normally used to measure LH release, no measurable (detection limit 0.02 n) ATP was secreted from GnRH-stimulated cells. Further experiments revealed that detection of ATP released from GnRH-stimulated cells was prevented by its rapid degradation in the presence of pituitary cells. When a column with 20 million cells was perifused at a rate of 0.15 ml/min, a 10-min pulse of 10 µ ATP was reduced to around 2 µ in the effluent, while a 1.2 µ pulse was degraded to less then 0.2 µ ATP. When the same pulses were applied to columns without cells, no significant degradation or adsorption of ATP was observed (Fig. 9A). Such a rapid degradation of ATP in the presence of the cells indicated the operation of ecto-ATPases. To permit the measurement of ATP secretion, several ecto-ATPase inhibitors were employed: N-ethylmaleimide, trifluoroperazine, etharinic acid, and the removal from external medium of Ca2+ and Mg2+, the ions required for activation of ecto-ATPases (27). Only a minor reduction of ecto-ATPase activity was observed in cells treated with these inhibitors or in cells perifused with Ca2+/Mg2+-deficient medium. However, the presence of Ca2+/Mg2+ chelators, EGTA or EDTA, in the medium significantly inhibited ATP degradation (Fig. 9B). Furthermore, EGTA increased the basal secretion of ATP from non-detectable to about 1 n.


Fig. 9. ATP concentration in the effluent of perifused pituitary cells. A, degradation of extracellular ATP by pituitary cells. Columns without cells (closed circles) and with cells (open circles) were exposed to pulses of ATP. B, inhibition of ATP degradation by removal of extracellular Ca2+ and Mg2+. Columns with cells were perifused by modified Krebs-Ringer, which contained no Mg2+ and 1.2 m Ca2+ (closed circles), Ca2+-deficient medium (triangles), and 1 m EGTA with no Ca2+ added (open circles). In panels A and B, the applied ATP concentration is indicated by the heights of shaded areas, and the pulse duration by their widths. C, GnRH-induced secretion of ATP. Cells were perifused with Ca2+/Mg2+-free Krebs-Ringer containing 1 m EDTA. The duration of the GnRH and ATP pulses is indicated by the width of shaded areas. In all experiments columns containing 20 million cells were perifused at a rate 0.17 ml/min, and samples were collected every 2 min.
[View Larger Version of this Image (42K GIF file)]

An increase in basal ATP was also detected in the effluent of EDTA-perifused cells; 10 min after switching to the perifusion medium containing 1 m EDTA, ATP concentration in the effluent was still rising. Nevertheless, a GnRH pulse further increased ATP levels (Fig. 9C). Cessation of GnRH stimulation was followed by a fall in ATP concentration to a plateau value, and a subsequent GnRH pulse induced an additional ATP response. After being washed, the cells were perifused with a 50 n ATP pulse, and only abut 10% of applied ATP remained in the effluent. The next pulse contained 200 n ATP and the corresponding plateau in the effluent was 25 n (data not shown). Therefore, the estimated concentration of GnRH-induced ATP secretion in medium containing 1 m EDTA under the described perifusion conditions is about 40 n, and most of the secreted amount is quickly degraded, leaving about 4 n in the effluent. GnRH-induced ATP secretion was observed in two out of three perifusion experiments (where all perifusion media contained EDTA), but was never detected in experiments where EDTA was not used.

To estimate the concentration of total adenosine nucleotides in the column perfusate and in culture medium of the cells plated on dishes, AMP and ADP in the medium were enzymatically converted to ATP prior to luminometric determination of ATP concentration. In the absence of the cells, 1 h of exposure to myokinase and pyruvate kinase was sufficient to rephosphorylate 96-99% of 1 µ AMP to ATP. However, in the presence of the cells in static cultures only about 17% of added 100 n or 1 µ ATP (in the medium containing 1.2 m Ca2+) was recovered (Table I), while in perifused cells no recovery was observed. These observations are consistent with conclusion that, in addition to ecto-ATPase, pituitary cells also express ectoADPase and ecto-5'-nucleotidase, thus, degrading ATP to adenosine.

Table I.

Concentration of ATP and total adenine nucleotides (AN) in n in medium of pituitary cells cultured in dishes

Cells were stimulated in the presence of 1.25 mM Ca2+. The concentration of the inhibitor of 5'-nucleotidase, alpha ,beta -methylene-ADP, was 50 µ. For luminometric determination of total adenosine nucleotides, AMP and ADP were enzymatically converted to ATP as described under ``Materials and Methods.''
Basal secretion +100 n ATP +1 µ ATP

ATP <0.02 0.1 1
AN <10 17 175
ATP (+alpha ,beta -Me-ADP) <2 <2 <2
AN (+alpha ,beta -Me-ADP) 25 100 870

Like ecto-ATPase, ecto-ADPase and ecto-5'-nucleotidase are also inhibited by depletion of Ca2+ and Mg2+ (27). In accord with this, in cells perifused with or bathed in EDTA-containing medium, more than 90% recovery of added ATP was detected. Furthermore, in Ca2+-containing medium, addition of 50 µ alpha ,beta -methylene-ADP, an inhibitor of 5'-ectonucleotidase (27, 28) led to almost complete recovery of exogeneously added ATP in static cultures and to about 40% recovery in perifusate. As shown in Table I, basal secretion of ATP also increased in cells exposed to alpha ,beta -methylene-ADP. These observations are consistent with conclusion that ATP is secreted by pituitary cells and rapidly degraded by ectonucleotidases to adenosine.


DISCUSSION

The expression of purinergic receptors in pituitary cells and the effects of ATP on basal LH release have already been reported (21, 42). Likewise, we have also observed that ATP induces LH release in perifused pituitary cells, with peak responses lower than those induced by GnRH, and similar to GnRH-induced LH plateaus. In contrast to agonist-induced LH release, ATP-induced gonadotropin secretion rapidly declined after reaching its peak. Such kinetics of LH release from perifused pituitary cells attached on beads differ from the sustained and slowly dropping [Ca2+]i responses to ATP in single gonadotrophs attached to coverslips. This discrepancy suggested that ATP is degraded by pituitary cells and that such degradation is faster in 2 × 107 cells attached on beads and stimulated at 37 °C (secretory studies), than in 106 cells cultured on coverslips and stimulated at room temperature ([Ca2+]i measurements). Indeed, our results demonstrated substantial ecto-nucleotidase activity in perifused pituitary cells, and somewhat lower activity in cells in static cultures.

The operation of ecto-nucleotidase in pituitary cells was consistent with the hypothesis that ATP is cosecreted by pituitary cells, and that mechanism for its degradation is needed to terminate the signal upon the removal of agonist. However, the only effective way to demonstrate the cosecretion of ATP is to inhibit ecto-nucleotidase activity. Through the use of Ca2+/Mg2+ chelator, EDTA, we were able to demonstrate the agonist-induced secretion of ATP by pituitary cells. The amplitude of these responses was below the threshold concentrations required for activation of purinergic receptors. However, experiments with rephosphorylation of AMP and ADP and inhibition of ecto-5'-nucleotidase by alpha ,beta -methylene-ADP (27, 28) have revealed that ATP concentration was much higher than that estimated in the presence of EDTA. It is also reasonable to speculate that the intercellular ATP concentration in intact tissue is higher than that measured in our experiments. Thus, it is possible that in pituitary tissue, where there is much less space between cells, the kinetics of ATP degradation by ecto-nucleotidase and its binding to the receptor have significant effects on signaling. For example, the significance of the geometry of a neuromuscular junction is shown in theoretically predicted current induced by released quanta of ATP (43).

The expression of P2 receptors, their coupling to Ca2+ signaling, gonadotropin secretion, and cosecretion of ATP with gonadotropins suggests that pituitary cells belong to group of secretory cells in which ATP serves as a positive feed-back element in agonist-induced [Ca2+]i signaling and exocytosis. Within the cells expressing P2 receptors, the effects observed in gonadotrophs are most comparable to those observed in chromaffin cells and PC12 cells. In these related cell types, ATP induced an inward current, increased [Ca2+]i, and catecholamine release (44, 45, 46). As in gonadotrophs, ATP does not release [Ca2+]i from internal stores in a subpopulation of chromaffin cells bathed in Ca2+-deficient medium (46). Finally, ATP is cosecreted during agonist- and depolarization-induced secretion of catecholamines (47).

A general feature of purinergic receptors is that their activation is associated with an increase in [Ca2+]i. Depending on the receptor type, increases in [Ca2+]i can be caused by increased InsP3 production and consequent Ca2+ release from intracellular pools (G protein/phospholipase C-coupled P2Y and P2U receptors) or by Ca2+ influx (P2X receptor channels) (5). Three lines of evidence argue against the hypothesis that rat pituitary gonadotrophs express G protein-coupled purinergic receptors. First, ATP did not induce [Ca2+]i responses in identified gonadotrophs bathed in Ca2+-deficient medium. Second, UTP, alpha ,beta -methylene-ATP, and beta ,gamma -methylene-ATP failed to induce a [Ca2+]i response. In a mixed population of pituitary cells, several cell types other than gonadotrophs responded to ATP and UTP in Ca2+-deficient medium, indicating the diversity of the expression of P2 receptors within the subpopulations of cells. In accord with this, the expression of P2U-purinoreceptors was found in pituitary lactotrophs (21) and mixed population of pituitary cells (17, 18). Third, experiments with permeabilized gonadotrophs showed that ATP did not induce Ca2+ release from the intracellular pool, whereas InsP3, as well as activation of G protein-coupled receptors by GnRH and ET-1, induced Ca2+ mobilization.

Our pharmacological and electrophysiological characterization of ATP-induced Ca2+ influx was consistent with the expression of P2X2 and/or P2X5 receptor channels in gonadotrophs. The comparable specificity of responses to these two cloned receptors was observed under a wide range of conditions (see ``Results''). On the other hand, P2 receptor channels in gonadotrophs are clearly distinct from the cloned P2X1, P2X3, P2X4, and P2X6 receptor channels (30, 31, 32, 33, 34, 35). Furthermore, although BzATP induced a rise in [Ca2+]i in gonadotrophs, it was equipotent with ATP, contrary to observations with native (29) and cloned (36) P2X7 receptor channels, which are more sensitive to BzATP. Additionally, permeabilization of gonadotrophs was not observed in response ATP or any of its analogues, again arguing against the expression of P2X7 receptor channels.

In contrast to well characterized structure and pharmacology, the physiological significance of these receptor channels is not well understood. In this regard, gonadotrophs represent an excellent cell model, especially since both plasma membrane- and ER-controlled Ca2+ oscillators are operative in these cells (11). We (22) and others (48, 49, 50) have identified the essential elements of the plasma membrane oscillator in gonadotrophs: T and L voltage-sensitive calcium channels, delayed-rectifier, and apamin-sensitive potassium channels, and plasma membrane (Ca2+)ATPase. Simultaneous measurements of electrical activity and [Ca2+]i in gonadotrophs demonstrated that a single AP is sufficient to drive a [Ca2+]i spike with an average amplitude of about 200 n above the basal level (22). Since spontaneous firing in lactotrophs and somatotrophs is sufficient to trigger exocytosis in these cells (51), it is reasonable to speculate that ATP is cosecreted with GH and prolactin and is involved in modulation of such electrical activity in an autocrine and/or paracrine manner.

The present data indicate that P2 receptor channels in gonadotrophs are not essential for spontaneous electrical activity, but that their stimulation can activate the plasma membrane oscillator and modulate its activity. As shown in patch-clamp studies, ATP gating of P2 receptor channels leads to an increase in [Ca2+]i that depolarizes gonadotrophs to levels that are sufficient to activate their plasma membrane oscillator in silent cells. In further accord with this, depolarizing current initiates firing of APs in quiescent gonadotrophs and modulates the frequency pattern of firing in spontaneously active cells (22). These observations in gonadotrophs parallel those in noradrenergic neurons, where enzymatically more stable analogues of ATP were found to increase the AP firing rate (12). Thus, ATP increases [Ca2+]i by two mechanisms, directly through P2 receptor channels and indirectly by activation of VSCC.

Gonadotrophs also express an ER oscillator, the operation of which is controlled by InsP3 and [Ca2+]i (52) in a manner comparable to that observed in oocytes, hepatocytes, and pancreatic acinar cells (53, 54, 55). During the prolonged agonist stimulation, non-excitable cells are supplied by Ca2+ through store-operated calcium channels (16), while in excitable gonadotrophs VSCC play such a role. Results from voltage-clamped gonadotrophs have indicated that Ca2+ entry through VSCC plays a minor role during the initial phase of intracellular Ca2+ mobilization. However, it sustains the operation of the ER oscillator as the InsP3-sensitive Ca2+ pool becomes depleted (15). The expression of the P2 receptor channels in the same cells may serve as an additional system to provide Ca2+ entry. As shown here, the ER oscillator is able to integrate Ca2+ entry through both VSCC and P2 channels. Similarly, the P2 receptor channels in non-excitable cells (7, 8, 9) may enhance Ca2+ influx controlled by store-operated calcium channels.

InsP3-controlled Ca2+ release from ER is highly synchronized with Ca2+ influx. Such synchronization is essential for prevention of possible remodulation of InsP3-induced [Ca2+]i spiking by Ca2+ entry (39). In general, these interactive regulatory events are complex. Our experiments dealing with the phase resetting of InsP3-dependent Ca2+ oscillations by membrane depolarization during the sustained phase revealed modulation of the frequency and amplitude of Ca2+ spiking in gonadotrophs (25, 56). Similarly, Ca2+ entry through store-operated calcium channels was shown to modulate the frequency of spiking in oocytes (57). Calcium entry through P2 receptor channels can also modulate the frequency of InsP3-controlled Ca2+ spiking even at high and presumably non-physiological concentrations of ATP. Thus, the ER oscillator in gonadotrophs has a high, but not unlimited, capacity to accommodate Ca2+ influx through both VSCC and P2 receptor channels without disrupting the oscillatory nature of Ca2+ signaling.

In conclusion, the present data indicate that, in addition to two subtypes of VSCC, pituitary gonadotrophs also express P2 calcium channels. ATP gating of these channels leads to an increase in Ca2+ influx and depolarization of the cells. Such ATP-induced depolarization is sufficient to initiate AP-driven [Ca2+]i oscillations in silent cells and to increase the firing rate in cells that are spontaneously active at the resting membrane potential, as well as to stimulate LH release in the absence of GnRH. Furthermore, ATP is able to amplify GnRH-induced Ca2+ signaling in single cells and LH secretion in perifused cells. The physiological significance of such an action of ATP is supported by the finding that ATP is cosecreted with gonadotropins during GnRH stimulation. To control the action of this positive feedback system, the ecto-ATPases in pituitary cells provide an efficient mechanism for the termination of signaling. Thus, pituitary gonadotrophs express a complete purinergic system for the self-potentiation of signaling and secretion. The loading of secretory granules with ATP and the expression of distinct subtypes of P2 receptors in other pituitary cell types indicate that ATP may also have an important role in cell-to-cell signaling within the pituitary gland.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: NICHD/ERRB, UCS, Bldg. 49, Rm. 6A-36, 49 Convent Dr., MSC 4510, Bethesda, MD 20892-4510. Tel.: 301-496-2136; Fax: 301-480-8010; E-mail: stankos{at}helix.nih.gov.
1   The abbreviations used are: P2, purinergic receptors; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; [Ca2+]i, cytosolic calcium concentration; ER, endoplasmic reticulum; VSCC, voltage-sensitive calcium channels; AP, action potential; ATPalpha S, adenosine-5'O-(1-thiotriphosphate); ATPgamma S, adenosine-5'-O-(3-thiotriphosphate); Bz-ATP, 3'-O-(4-benzoyl)benzoyl-ATP; BSA, bovine serum albumin; PIPES, 1,4-piperazinediethanesulfonic acid; InsP3, inositol 1,4,5-trisphosphate.

REFERENCES

  1. Burnstock, G. (1993) Drug Dev. Res. 28, 195-206 [CrossRef]
  2. Harden, T. K., Boyer, J. L., Nicholas, R. A. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 541-579 [CrossRef][Medline] [Order article via Infotrieve]
  3. Chen, Z.-P., Levy, A., Lightman, S. L. (1995) J. Neuroendocrinol. 7, 83-96 [CrossRef][Medline] [Order article via Infotrieve]
  4. Cusack, N. J. (1993) Drug Dev. Res. 28, 244-252 [CrossRef]
  5. Abbracchio, M. P., Burnstock, G. (1994) Pharmacol. Ther. 64, 445-475 [CrossRef][Medline] [Order article via Infotrieve]
  6. Benham, C. D., Tsien, R. W. (1987) Nature 328, 275-278 [CrossRef][Medline] [Order article via Infotrieve]
  7. Greenberg, S., Di Virgilio, F., Steinberg, T. H., Silvestein, S. C. (1988) J. Biol. Chem. 263, 10337-10343 [Abstract/Free Full Text]
  8. Wiley, J. S., Chen, R., Jamieson, G. P. (1993) Arch. Biochem. Biophys. 305, 54-60 [CrossRef][Medline] [Order article via Infotrieve]
  9. Rozengurt, E., Heppler, L. A. (1975) Biochem. Biophys. Res. Commun. 67, 1581-1588 [CrossRef][Medline] [Order article via Infotrieve]
  10. Bean, B. P. (1992) Trends Pharmacol. Sci. 13, 87-90 [CrossRef][Medline] [Order article via Infotrieve]
  11. Stojilkovic, S. S., Catt, K. J. (1992) Endocr. Rev. 13, 256-280 [Abstract/Free Full Text]
  12. Tschopl, M., Harms, L., Norenberg, W., Illes, P. (1992) Eur. J. Pharmacol. 213, 71-77 [CrossRef][Medline] [Order article via Infotrieve]
  13. Rooney, T. A., Sass, E. J., Thomas, A. P. (1989) J. Biol. Chem. 264, 17131-17141 [Abstract/Free Full Text]
  14. Zhao, H., Loessberg, P. A., Sachs, G., Muallem, S. (1990) J. Biol. Chem. 265, 20856-20862 [Abstract/Free Full Text]
  15. Stojilkovic, S., Kukuljan, M., Iida, T., Rojas, E., Catt, K. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4081-4085 [Abstract/Free Full Text]
  16. Putney, J. W., Jr., Bird, G., St, J. (1993) Endocr. Rev. 14, 610-631 [Abstract/Free Full Text]
  17. Van Der Merwe, P. A., Wakefield, I. K., Fine, J., Millar, R. P., Davidson, J. S. (1989) FEBS Lett. 243, 333-336 [CrossRef][Medline] [Order article via Infotrieve]
  18. Davidson, J. S., Wakefield, I. K., Sohnius, U., Van Der Merwe, P. A., Millar, R. P. (1990) Endocrinology 126, 80-87 [Abstract/Free Full Text]
  19. Chen, Z.-P., Kratzmeier, M., Levy, A., McArdle, C. A., Poch, A., Day, A., Mukhopadhyay, A. K., Lightman, S. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5219-5223 [Abstract/Free Full Text]
  20. Chen, Z.-P., Kratzmeier, M., Poch, A., Xu, S., McArdle, G. A., Levy, A., Mukhopadhyay, A. K., Lightman, S. L. (1996) Endocrinology 137, 248-256 [Abstract]
  21. Carew, M. A., Wu, M.-L., Law, G. J., Tseng, Y.-Z., Mason, W. T. (1994) Cell Calcium 16, 227-235 [CrossRef][Medline] [Order article via Infotrieve]
  22. Li, Y.-X., Rinzel, J., Vergara, L., Stojilkovic, S. S. (1995) Biophys. J. 69, 785-795 [Medline] [Order article via Infotrieve]
  23. Hofer, A. M., Machen, T. E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2598-2602 [Abstract/Free Full Text]
  24. Jobin, R. M., Tomic, M., Zheng, L., Stojilkovic, S. S., Catt, K. J. (1995) Endocrinology 136, 3398-3405 [Abstract]
  25. Vergara, L., Stojilkovic, S. S., Rojas, E. (1995) Biophys. J. 69, 1606-1614 [Medline] [Order article via Infotrieve]
  26. Stojilkovic, S. S., Stutzin, A., Izumi, S.-I., Dufour, S., Torsello, A., Virmani, M. A., Rojas, E., Catt, K. J. (1990) New Biol. 3, 272-283
  27. Pearson, J. D. (1985) Methods Pharmacol. 6, 83-107
  28. Deussen, A., Bading, B., Kelm, M., Schrader, J. (1993) Am. J. Physiol. 264, H692-H700 [Abstract/Free Full Text]
  29. Nuttle, L. C., Dubyak, G. R. (1994) J. Biol. Chem. 269, 13988-13996 [Abstract/Free Full Text]
  30. Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., Buell, G. (1994) Nature 371, 516-519 [CrossRef][Medline] [Order article via Infotrieve]
  31. Chen, C.-C., Akopian, A. N., Sivilotti, L., Colquhoun, D., Burnstock, G., Wood, J. N. (1995) Nature 377, 428-431 [CrossRef][Medline] [Order article via Infotrieve]
  32. Lewis, C., Neidhart, S., Holy, C., North, R. A., Buell, G., Surprenant, A. (1995) Nature 377, 432-435 [CrossRef][Medline] [Order article via Infotrieve]
  33. Bo, X., Zhang, Y., Nassar, M., Burnstock, G., Schoepfer, R. (1995) FEBS Lett. 375, 129-133 [CrossRef][Medline] [Order article via Infotrieve]
  34. Buell, G., Lewis, C., Collo, G., North, R. A., Surprenant, A. (1996) EMBO J. 15, 55-62 [Medline] [Order article via Infotrieve]
  35. Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., Buell, G. (1996) J. Neurosci. 16, 2495-2507 [Abstract/Free Full Text]
  36. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., Buell, G. (1996) Science 272, 735-738 [Abstract]
  37. Brake, A. J., Wagenbach, M. J., Julius, D. (1994) Nature 371, 519-523 [CrossRef][Medline] [Order article via Infotrieve]
  38. Iida, T., Stojilkovic, S. S., Izumi, S.-I., Catt, K. J. (1991) Mol. Endocrinol. 5, 949-958 [Abstract/Free Full Text]
  39. Keizer, J., Li, Y.-X., Stojilkovic, S. S., Rinzel, J. (1995) Mol. Biol. Cell 6, 945-951 [Abstract]
  40. Zhang, B.-X., Muallem, S. (1992) J. Biol. Chem. 267, 24387-24393 [Abstract/Free Full Text]
  41. Bezprozvanny, I., Watras, J., Ehrlich, B. E. (1991) Nature 351, 751-754 [CrossRef][Medline] [Order article via Infotrieve]
  42. Chen, Z.-P., Levy, A., McArdle, C. A., Lightman, S. L. (1994) Endocrinology 135, 1280-1284 [Abstract]
  43. Bennett, M. R., Farnell, L., Gibson, W. G., Karunanithi, S. (1995) Biophys. J. 68, 925-935 [Medline] [Order article via Infotrieve]
  44. Illes, P., Norenberg, W. (1993) Trends Pharmacol. Sci. 14, 50-54 [CrossRef][Medline] [Order article via Infotrieve]
  45. Kim, K.-T., Westhead, W. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9881-9885 [Abstract/Free Full Text]
  46. Castro, E., Mateo, J., Tomé, A. R., Barbosa, R. M., Miras-Portugal, M. T., Rosário, L. M. (1995) J. Biol. Chem. 270, 5098-5106 [Abstract/Free Full Text]
  47. Cena, V., Rojas, E. (1990) Biochim. Biophys. Acta 1023, 213-222 [Medline] [Order article via Infotrieve]
  48. Bosma, M. M., Hille, B. (1992) Endocrinology 130, 3411-3420 [Abstract/Free Full Text]
  49. Tse, A., Hille, B. (1993) Endocrinology 132, 1475-1481 [Abstract/Free Full Text]
  50. Marchetti, C., Childs, G. V., Brown, A. M. (1987) Am. J. Physiol. 252, E340-E346 [Abstract/Free Full Text]
  51. Stojilkovic, S. S., Izumi, S.-I., Catt, K. J. (1988) J. Biol. Chem. 263, 13054-13061 [Abstract/Free Full Text]
  52. Stojilkovic, S. S., Tomic, M., Kukuljan, M., Catt, K. J. (1994) Mol. Pharmacol. 45, 1013-1021 [Abstract]
  53. Loessberg, P. A., Zhao, H., Muallem, S. (1991) J. Biol. Chem. 266, 1363-1366 [Abstract/Free Full Text]
  54. Lechleiter, J. D., Clapham, D. E. (1992) Cell 69, 283-294 [CrossRef][Medline] [Order article via Infotrieve]
  55. Rooney, T. A., Sass, E. J., Thomas, A. P. (1990) J. Biol. Chem. 265, 10792-10796 [Abstract/Free Full Text]
  56. Kukuljan, M., Rojas, E., Catt, K. J., Stojilkovic, S. S. (1994) J. Biol. Chem. 269, 4860-4865 [Abstract/Free Full Text]
  57. Girard, S., Clapham, D. (1993) Science 260, 229-232 [Abstract/Free Full Text]
  58. Horn, R., Marty, A. (1988) J. Gen. Physiol. 92, 145-159 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Zemkova, A. Balik, Y. Jiang, K. Kretschmannova, and S. S. Stojilkovic
Roles of Purinergic P2X Receptors as Pacemaking Channels and Modulators of Calcium-Mobilizing Pathway in Pituitary Gonadotrophs
Mol. Endocrinol., June 1, 2006; 20(6): 1423 - 1436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. A. P. Chaves, E. P. Pontelli, and W. A. Varanda
P2X receptors in mouse Leydig cells
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1009 - C1017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Terasawa, K. L. Keen, R. L. Grendell, and T. G. Golos
Possible Role of 5'-Adenosine Triphosphate in Synchronization of Ca2+ Oscillations in Primate Luteinizing Hormone-Releasing Hormone Neurons
Mol. Endocrinol., November 1, 2005; 19(11): 2736 - 2747.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. J Winters and J. P Moore
Intra-pituitary regulation of gonadotrophs in male rodents and primates
Reproduction, July 1, 2004; 128(1): 13 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. He, A. E. Gonzalez-Iglesias, and S. S. Stojilkovic
Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs
J. Biol. Chem., November 21, 2003; 278(47): 46270 - 46277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Heteromultimerization Modulates P2X Receptor Functions through Participating Extracellular and C-terminal Subdomains
J. Biol. Chem., November 27, 2002; 277(49): 46891 - 46899.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-a. Koshimizu, M. Tomic, A. O.-L. Wong, D. Zivadinovic, and S. S. Stojilkovic
Characterization of Purinergic Receptors and Receptor-Channels Expressed in Anterior Pituitary Cells
Endocrinology, November 1, 2000; 141(11): 4091 - 4099.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Schwartz
Intercellular Communication in the Anterior Pituitary
Endocr. Rev., October 1, 2000; 21(5): 488 - 513.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
L. Chen, D. Maruyama, M. Sugiyama, T. Sakai, C. Mogi, M. Kato, R. Kurotani, N. Shirasawa, A. Takaki, U. Renner, et al.
Cytological Characterization of a Pituitary Folliculo-Stellate-Like Cell Line, Tpit/F1, with Special Reference to Adenosine Triphosphate-Mediated Neuronal Nitric Oxide Synthase Expression and Nitric Oxide Secretion
Endocrinology, October 1, 2000; 141(10): 3603 - 3610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E.'I. Nakamura, Y. Uezono, K.'I. Narusawa, I. Shibuya, Y. Oishi, M. Tanaka, N. Yanagihara, T. Nakamura, and F. Izumi
ATP activates DNA synthesis by acting on P2X receptors in human osteoblast-like MG-63 cells
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C510 - C519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D.-M. Zhao, H.-H. Xue, K. Chida, T. Suda, Y. Oki, M. Kanai, C. Uchida, A. Ichiyama, and H. Nakamura
Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L726 - L736.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. J. Lynch, E. Touma, W. Niforatos, K. L. Kage, E. C. Burgard, T. van Biesen, E. A. Kowaluk, and M. F. Jarvis
Molecular and Functional Characterization of Human P2X2 Receptors
Mol. Pharmacol., December 1, 1999; 56(6): 1171 - 1181.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. C. Katzur, T.-A. Koshimizu, M. Tomic, A. Schultze-Mosgau, O. Ortmann, and S. S. Stojilkovic
Expression and Responsiveness of P2Y2 Receptors in Human Endometrial Cancer Cell Lines
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4085 - 4091.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
J.-D. Troadec, S. Thirion, G. Nicaise, J. R Lemos, and G. Dayanithi
ATP-evoked increases in [Ca2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor
J. Physiol., August 15, 1998; 511(1): 89 - 103.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T.-a. Koshimizu, M. Tomic, F. Van Goor, and S. S. Stojilkovic
Functional Role of Alternative Splicing in Pituitary P2X2 Receptor-Channel Activation and Desensitization
Mol. Endocrinol., July 1, 1998; 12(7): 901 - 913.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Nunez and L. S. Frawley
alpha -MSH potentiates the responsiveness of mammotropes by increasing Ca2+ entry
Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E971 - E977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, M. Tomic, M. Koshimizu, and S. S. Stojilkovic
Identification of Amino Acid Residues Contributing to Desensitization of the P2X2 Receptor Channel
J. Biol. Chem., May 22, 1998; 273(21): 12853 - 12857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Villalobos, S. R. Alonso-Torre, L. Nunez, and J. Garcia-Sancho
Functional ATP receptors in rat anterior pituitary cells
Am J Physiol Cell Physiol, December 1, 1997; 273(6): C1963 - C1971.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jobin, R. M.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jobin, R. M.
Right arrow Articles by Stojilkovic, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement